Subclinical systolic dysfunction in pediatric patients with chronic kidney disease

Donald J Weaver1, Thomas Kimball, Sandra A Witt

  • 1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

Insights

Children with chronic kidney disease (CKD) undergoing hemodialysis show reduced midwall shortening (mwSF), indicating subclinical systolic dysfunction. This finding highlights potential risks for developing severe cardiac disease in pediatric CKD patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pediatrics

Background:

  • Midwall shortening (mwSF) is a key indicator of myocardial performance, particularly in left ventricular hypertrophy (LVH).
  • Assessing mwSF in pediatric chronic kidney disease (CKD) is crucial for understanding cardiac health in this vulnerable population.

Purpose of the Study:

  • To evaluate midwall shortening (mwSF) in pediatric patients across various stages of chronic kidney disease (CKD).
  • To compare mwSF in children undergoing hemodialysis, kidney transplant recipients, and healthy controls.

Main Methods:

  • Echocardiographic assessment of left ventricular (LV) geometry and function in 57 children with CKD (stages 2-4), 25 on hemodialysis, 49 transplant recipients, and 35 healthy controls.
  • Comparison of mwSF and other LV function indices between patient groups and controls.

Main Results:

  • Patients on hemodialysis exhibited significantly lower mwSF compared to controls and CKD stages 2-4 patients (P < .01).
  • Renal transplant recipients also showed lower mwSF than controls (P < .01).
  • Abnormal mwSF prevalence was highest in hemodialysis patients (40%) versus transplant recipients (12%) and CKD stages 2-4 patients (9%; P = .03).

Conclusions:

  • Children on maintenance hemodialysis and those with concentric LVH demonstrate subclinical systolic dysfunction.
  • This subclinical dysfunction may signal an increased risk for developing more severe cardiac conditions.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...